Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? [electronic resource]
Producer: 20020513Description: 1293-302 p. digitalISSN:- 0360-3016
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Combined Modality Therapy
- Deoxycytidine -- adverse effects
- Disease Progression
- Female
- Fluorouracil -- adverse effects
- Humans
- Male
- Middle Aged
- Pancreatic Neoplasms -- drug therapy
- Pancreaticoduodenectomy
- Radiation-Sensitizing Agents -- adverse effects
- Retrospective Studies
- Survival Analysis
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.